Physician profile
Suhail Haque
NPI 1821048513
$2,053.90
in general payments reported to CMS, 2019-2025
21 companies · $99.43 in 2025
The $99.43 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $283 · 2020: $308 · 2021: $916 · 2022: $13.71 · 2023: $309 · 2024: $125 · 2025: $99.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $533.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $533.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $365.78 | 2023-2025 | Evoke, Evoke Scs |
| Medtronic USA, INC. | $278.38 | 2019-2020 | |
| Nevro Corp. | $263.23 | 2021-2023 | Senza |
| Si-Bone, INC. | $247.64 | 2019-2021 | |
| Boston Scientific Corporation | $148.43 | 2021 | |
| Grt US Holding, INC. | $127.20 | 2021-2022 | |
| Pfizer INC. | $98.98 | 2020-2021 | |
| Arbor Pharmaceuticals, INC. | $70.68 | 2020-2021 | |
| Collegium Pharmaceutical, INC. | $61.20 | 2019-2021 | |
| Averitas Pharma INC. | $60.88 | 2023 | Qutenza |
| Allergan, INC. | $60.00 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $57.39 | 2021 | |
| Ibsa Pharma INC. | $47.20 | 2021 | |
| Stimwave Technologies Incorporated | $32.43 | 2020 | |
| Tersera Therapeutics LLC | $29.03 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $27.44 | 2023 | Sublocade |
| Idorsia Pharmaceuticals US INC | $25.71 | 2023 | Quviviq |
| Abbvie INC. | $14.10 | 2023 | |
| Biodelivery Sciences International, INC. | $13.56 | 2021 | |
| Currax Pharmaceuticals LLC | $12.72 | 2021 | |
| Flowonix Medical Incorporated | $11.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suhail Haque listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.